Interestingly, M-MDSCs and PMN-MDSCs were significantly higher in PB-HCC as compared to PB-CRLM, in accordance with low CD8+ effector cells (CD8+CD45R4+CD62L−) in PB-HCC (Fig. 1c). This evidence concerns the gene SELL and hepatocellular carcinoma.